Key Findings

The study developed a DNA microarray to detect mutations in genes associated with resistance to five antituberculosis drugs, including isoniazid, rifampicin, streptomycin, kanamycin, and ethambutol. The microarray showed high sensitivity for all five drugs but variable specificity, particularly for isoniazid and kanamycin.